Investing Profile

Jeffrey Finer

InvestorVC
Venture Partner at Third Rock Ventures
thirdrockventures.com/people/...South San Francisco, California
Photo of Jeffrey Finer, Venture Partner at Third Rock Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Massachusetts Institute of Technology Network
546 CONNECTIONS
Stanford Center for Clinical Research (SCCR) Network
55 CONNECTIONS
Third Rock Ventures Network
50 CONNECTIONS
Stanford University School of Medicine Network
40 CONNECTIONS
cb
Third Rock Ventures Venture Partner
$100K - $5.0M
$1.5M
2
$770M
CompanyStageDateRound SizeTotal Raised
Septerna
Series BJul 2023$150M
Series AJan 2022$100M
$250M
Co-investors: Alan Ezekowitz (Third Rock Ventures), Abe Bassan (Samsara BioCapital), Jeffrey Tong (Third Rock Ventures), Jake Simson (RA Capital Management)
drug discovery
Resident Physician, Internal Medicine Stanford Center for Clinical Research (SCCR)Present
Resident Physician & Surgeon, Ophthalmology Massachusetts Eye and EarPresent
Director, Drug Discovery Technologies CytokineticsPresent
Vice President, Discovery Five Prime TherapeuticsPresent
Vice President, Molecular & Cellular Biology Theravance Biopharma US, LLCPresent
Vice President, Research Technology Theravance Biopharma US, LLCPresent
Interim Chief Technology Officer Maze TherapeuticsPresent
Interim Chief Technology Officer Ambys MedicinesPresent
Board Member TranscripticPresent
Board Chairman StrateosPresent
Board Observer Ambys MedicinesPresent
Board Member StrateosPresent
Board Observer Maze TherapeuticsPresent
Venture Partner Third Rock VenturesPresent
CEO and Co-Founder SepternaPresent
Massachusetts Institute of Technology BS Chemistry
Stanford University School of Medicine MD PhD Biophysics, Medicine
Sign in with Google →
Sign in with Google →